DPP4 and type 2 diabetes mellitus: However, it remained uncertain whether DPP4 could reduce BDNF ratio (DBR) by targeting increased plasma DPP4 activity, thereby improving MCI in older patients with type 2 diabetes (Zheng et al., 2018).